Bruch's membrane opening minimum rim width and retinal nerve fiber layer thickness in a Brazilian population of healthy subjects by Camila S. Zangalli (6095888)

“…In all races, global MRW decreased and global RNFLT increased with BMO area. …”

DataSheet_1_PET/CT imaging detects intestinal inflammation in a mouse model of doxorubicin-induced mucositis.docx by Sina Dalby (14262449)

“…In the doxorubicin group, the largest weight loss was observed on day 3 (control vs doxorubicin, mean percent of baseline weight: (98.5 ± 3.2% vs 87.9 ± 4.6%, p < 0.0001). …”

Data_Sheet_1_Association of Exercise With Vascular Function in Patients With CKD: A Meta-Analysis of Randomized Controlled Trials.docx by Huan Wang (109286)

“…Exercise training was significantly associated with decreased pulse wave velocity weighted mean difference (WMD), −0.56; 95% confidence interval (CI), −1.02 to −0.09, P = 0.02 and augmentation index (WMD, −3.26; 95% CI, −5.46 to −1.05, P = 0.004). …”

STUDYING THE GRAMMAGE IN LVL PANELS GLUED WITH CASTOR OIL-BASED POLYURETHANE ADHESIVE: A POSSIBLE ALTERNATIVE TO FORMALDEHYDE RELEASING ADHESIVES. by Douglas Lamounier Faria (6074903)

Evaluation of antimicrobial and non-steroidal anti-inflammatory treatments for BRD on health and welfare in fattening bulls: a cross-sectional study by Naod Thomas Masebo (18512940)

Supplementary Material for: Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure by figshare admin karger (2628495)

Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagy in a mouse model of BRCA1-deficient breast cancer by Syn Kok Yeo (5539910)

The impact of body mass index (BMI) variation on mortality of incident elderly patients on peritoneal dialysis: a joint model analysis by Marcia Regina Gianotti Franco (12731178)

Supplementary Material for: Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease by Chen T.-B. (4273591)

Efficacy of injectable platelet-rich fibrin in the erosive oral lichen planus: a split-mouth, randomized, controlled clinical trial by Ebru SAGLAM (12681383)

Image 9_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”

Image 6_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”

Image 10_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”

Image 1_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”

Image 3_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”

Image 8_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”

Image 7_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”

Image 4_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”

Image 2_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”

Data Sheet 1_Longitudinal analysis of usage and public awareness of tyrosine kinase inhibitors for CML.docx by Adrian E. Schroer (17937971)